Hot Managed Healthcare Companies To Invest In 2014

If the first quarter, insurers reported increases in their insurance premiums as a means to offset some losses from higher claims. American International Group (NYSE: AIG  ) reported a 6% increase in their commercial lines alone, while Allstate (NYSE: ALL  ) reported a 2.5% growth in written premiums due in part to higher rates. But should investors be happy that insurers are increasing their premiums?

In the video below, Motley Fool contributor Jessica Alling discusses why insurers are raising their rates, why this may be a good thing, and how investors should look at the insurers going forward.�

At the end of last year, AIG was the favorite stock among hedge fund managers. Have they identified the next big multi-bagger, or are the risks facing the insurance giant still too great? In The Motley Fool's premium report on AIG, Financials Bureau Chief Matt Koppenheffer breaks down the key issues that you need to know about if you want to successfully invest in this stock. Simply click here now to claim your copy, and you'll also receive a full year of key updates and expert analysis as news continues to develop.

Top 5 Tech Companies To Buy For 2015: Sysco Corporation(SYY)

Sysco Corporation, through its subsidiaries, distributes food and related products primarily to the foodservice or food-away-from-home industry in North America and Europe. The company offers a line of frozen foods, such as meats, fully prepared entrees, fruits, vegetables, and desserts; a line of canned and dry foods; fresh meats, custom-cut fresh steaks, other meat, seafood, and poultry; dairy products; beverage products; imported specialties; and fresh produce. It also supplies various non-food items, including paper products, such as disposable napkins, plates, and cups; tableware, which include china and silverware; cookware comprising pots, pans, and utensils; restaurant and kitchen equipment and supplies; and cleaning supplies. In addition, the company offers personal care guest amenities, equipment, housekeeping supplies, room accessories, and textiles to the lodging industry. It serves restaurants, hospitals and nursing homes, schools and colleges, hotels and mote ls, lodging establishments, and other foodservice customers. Sysco Corporation was founded in 1969 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By GURUFOCUS]

  Linked here is a detailed quantitative analysis of Sysco Corporation (SYY). Below are some highlights from the above linked analysis:
  
  Company Description: Sysco Corporation is a large distributor of food and related products, primarily to the foodservice or food-away-from-home industry.

• [By Holly LaFon]

  ��Sysco Corp. (SYY), a food distributor, announced disappointing earnings as weakness in its end markets has made it difficult to achieve anticipated revenue growth targets.

• [By GuruFocus]

  Reduced: Sysco Corporation (SYY)

  Tom Gayner reduced to his holdings in Sysco Corporation by 92.56%. His sale prices were between $33.35 and $35.24, with an estimated average price of $34.43. The impact to his portfolio due to this sale was -0.38%. Tom Gayner still held 23,382 shares as of 06/30/2013.

Hot Managed Healthcare Companies To Invest In 2014: Zynga Inc (ZNGA)

Zynga Inc. (Zynga), is a provider of social game services with 240 million average monthly active users over 175 countries. The Company develops, markets and operates online social games as live services played over the Internet and on social networking sites and mobile platforms. The Company�� games are accessible on Facebook, other social networks and mobile platforms to players globally, wherever and whenever they want. It operates its games as live services. All of its games are free to play, and it generates revenue through the in-game sale of virtual goods and advertising. In March 2012, the Company acquired New York-based social game developer OMGPOP, makers of the cultural hit mobile game, Draw Something, and over 35 additional social games. In 2012, the Company launched several new games, including Hidden Chronicles, Zynga Bingo, Scramble With Friends, Slingo and Dream Heights.

Social Games

The Company designs its social games to provide players with shared experiences. Its social games leverage the global connectivity and distribution on Facebook, other social networks and mobile platforms, such as Apple iOS and Google Android. Its games are free to play, span a number of genres. It operates its games as live services and updates them with content and features. Its games include CityVille, Zynga Poker, FarmVille, CastleVille, FrontierVille, Mafia Wars and Word with Friends.

Virtual Goods

The Company�� primary revenue source is the sale of virtual currency, which players use to buy in-game virtual goods. Some forms of virtual currency are earned through game play, while other forms can only be acquired for cash or, in some cases, by accepting promotional offers from its advertising partners.

Advertising

The Company�� advertising services offer ways for marketers and advertisers to reach and engage with its players. Its advertising offerings include branded virtual goods and sponsorships, engagement ads, mobil! e ads and display Ads. It offers branded virtual goods and sponsorships integrate advertising within game play; Engagement Ads and Offers, in which players can answer certain questions or sign up for third party services to receive virtual currency; Mobile Ads through ad-supported free versions of its mobile games such as Words with Friends and Display Ads in its online web games include banner advertisements.

The Company competes with Crowdstar, Inc., DeNA, Electronic Arts Inc., King.com, The Walt Disney Company, Vostu, Ltd. wooga GmbH, Amazon.com, Inc., Facebook, Inc., Google Inc., Microsoft Corporation , Tencent Holdings Limited, Apple, Electronic Arts, GREE, DeNA Co. Ltd., Gameloft, Glu Mobile, Rovio Mobile Ltd , Storm8, Inc., Activision Blizzard, Inc., Big Fish Games, Inc., Electronic Arts, SEGA of America, Inc., and THQ Inc..

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Zynga (NASDAQ: ZNGA  ) , a developer and marketer of online social games, dropped as much as 14% after the company announced plans to cut jobs and guided toward the low end of its previous bookings forecast.

• [By Steve Symington]

  A little over a month ago, I wondered if Zynga's (NASDAQ: ZNGA  ) terrible first-quarter results�had marked the beginning of the end for the social-gaming specialist.

Hot Managed Healthcare Companies To Invest In 2014: Royal Dutch Shell PLC (RDSA)

Royal Dutch Shell plc (Shell), incorporated on February 5, 2002, is an independent oil and gas company. The Company owns, directly or indirectly, investments in the numerous companies constituting Shell. Shell is engaged worldwide in the principal aspects of the oil and gas industry and also has interests in chemicals and other energy-related businesses. The Company operates in three segments: Upstream, Downstream and Corporate. Upstream combines the operating segments Upstream International and Upstream Americas, which are engaged in searching for and recovering crude oil and natural gas; the liquefaction and transportation of gas; the extraction of bitumen from oil sands that is converted into synthetic crude oil, and wind energy. Downstream is engaged in manufacturing; distribution and marketing activities for oil products and chemicals, in alternative energy (excluding wind), and carbon dioxide (CO2) management. Corporate represents the key support functions, comprising holdings and treasury, headquarters, central functions and Shell�� self-insurance activities. In October 2011, the Company bought a marine terminal on Canada's Pacific Coast as a possible site for a liquefied natural gas export terminal. In January 2012, the Company's 50% owned, Australia Arrow Energy Holdings Pty Ltd acquired all of the shares in Bow Energy Ltd. In January 2014, Royal Dutch Shell plc completed the acquisition of Repsol S.A.'s liquefied natural gas (LNG) portfolio outside North America.

Upstream International manages the Upstream businesses outside the Americas. It searches for and recovers crude oil and natural gas, liquefies and transports gas, and operates the upstream and midstream infrastructure necessary to deliver oil and gas to market. Upstream International also manages Shell�� entire liquefied petroleum gas (LNG) business, gas to liquids (GTL) and the wind business in Europe. Its activities are organized primarily within geographical units, although there are some activities that are mana! ged across the businesses or provided through support units.

Upstream Americas manages the Upstream businesses in North and South America. It searches for and recovers crude oil and natural gas, transports gas and operates the upstream and midstream infrastructure necessary to deliver oil and gas to market. Upstream Americas also extracts bitumen from oil sands that is converted into synthetic crude oil. Additionally, it manages the United States-based wind business. It comprises operations organized into business-wide managed activities and supporting activities.

Downstream manages Shell�� manufacturing, distribution and marketing activities for oil products and chemicals. These activities are organized into globally managed classes of business, although some are managed regionally or provided through support units. Manufacturing and supply includes refining, supply and shipping of crude oil. Marketing sells a range of products including fuels, lubricants, bitumen and liquefied petroleum gas (LPG) for home, transport and industrial use. Chemicals produces and markets petrochemicals for industrial customers, including the raw materials for plastics, coatings and detergents. Downstream also trades Shell�� flow of hydrocarbons and other energy-related products, supplies the Downstream businesses, markets gas and power and provides shipping services. Downstream additionally oversees Shell�� interests in alternative energy (including biofuels, and excluding wind) and CO2 management.

Projects and Technology manages the delivery of Shell�� major projects and drives the research and innovation to create technology solutions. It provides technical services and technology capability covering both Upstream and Downstream activities. It is also responsible for providing functional leadership across Shell in the areas of health, safety and environment, and contracting and procurement.

Advisors' Opinion:

• [By Jeff Reeves]

  The largest dedicated Europe ETF by assets is the Vanguard FTSE Europe ETF (VGK), with about $13 billion under management. Top holdings include U.K.-based Royal Dutch Shell (RDSA), Swiss consumer products maker Nestle (NSRGY) and HSBC.

• [By WALLSTCHEATSHEET]

  Royal Dutch Shell is an oil and gas company that operates worldwide. The company has just announced a new CEO that is bringing a different vision with him. The stock is trading near lows for the year but a new CEO may be the catalyst that the stock needs. Over the last four quarters, earnings have been mixed while revenue figures have been declining. Relative to its peers and sector, Royal Dutch Shell has been a weak year-to-date performer. WAIT AND SEE what this new CEO does for the company.

• [By WALLSTCHEATSHEET]

  Royal Dutch Shell is focused on oil and gas exploration and distribution, with operations all around the world. The company has agreed to sell a stake in one of its Brazilian offshore assets to Qatar�� state-owned oil and gas company for $1bn. The stock has struggled this year and is currently pulling back. Over the last four quarters, earnings have been decreasing and revenues have been mixed, which has produced conflicting feelings among investors. Relative to its peers and sector, Royal Dutch Shell has been a relative year-to-date performance leader. WAIT AND SEE what Royal Dutch Shell does this quarter.

• [By Inyoung Hwang]

  BP rallied the most since January 2011 after Europe�� third-largest oil company also increased its dividend. Royal Dutch Shell Plc (RDSA), the region�� biggest crude producer, rose 1.5 percent. Lloyds Banking Group Plc (LLOY) lost 2 percent after reporting that its loss widened in the third quarter.

Hot Managed Healthcare Companies To Invest In 2014: Protalix Biotherapeutics Inc (PLX)

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.

Taliglucerase Alfa

Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell�� cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.

PRX-102

The Company is developing PRX-102, its plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.

Acetylcholinesterase

Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.

As of December 31, 2010, its in-vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.

pr-antiTNF

pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.

The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.

Advisors' Opinion:

• [By Keith Speights]

  Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX  ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."

Hot Managed Healthcare Companies To Invest In 2014: Pacer International Inc.(PACR)

Pacer International, Inc., together with its subsidiaries, provides asset-light transportation and logistics services primarily in North America, Asia, Europe, Australia, South America, and Africa. It operates in two segments, Intermodal and Logistics. The Intermodal segment offers intermodal rail transportation, local cartage and trucking, intermodal marketing services, container capacity, on-site operational services, and door-to-door shipment management services. As of December 31, 2011, its equipment fleet consisted of 1,592 double-stack railcars, 18,183 containers, and 12,783 chassis. The Logistics segment provides highway brokerage, warehousing and distribution, international freight forwarding, ocean and air shipping, and supply chain management services, as well as offers non-vessel-operating common carrier to end-user customers. The company markets and supports its services to cargo owners, steamship lines, truckload carriers, truck brokers, and freight forwarders , as well as other third party transportation service providers, such as intermodal marketing companies, third-party logistics companies, and shippers? agents through its direct sales and customer service representatives. Pacer International, Inc. was founded in 1974 and is headquartered in Dublin, Ohio.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  XPO Logistics (NYSE: XPO) shot up 7.06 percent to $30.01 after the company announced its plans to acquire Pacer International (NASDAQ: PACR) in a deal valued at $335 million.

• [By Vera Yuan]

  Pacer International, Inc. (PACR) was acquired by XPO Logistics, Inc. which remains in our portfolio. We eliminated our position in specialty pharmaceutical company Actavis PLC (ACT) as the price to intrinsic value relationship narrowed. We originally received shares when Actavis bought portfolio holding Warner Chilcott. We eliminated our position in convenience store distributor Core- Mark Holding Co., Inc.( CORE) as the stock rose almost 40% over the last year and reached our estimate of intrinsic value.

Hot Managed Healthcare Companies To Invest In 2014: Aussie/New Zealand (AR)

Antero Resources Corporation operates as an oil and natural gas exploration and production company. The company focuses on the acquisition, development, and production of unconventional oil and liquids-rich natural gas properties primarily in West Virginia, Ohio, and Pennsylvania. It was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. The company was founded in 2002 and is based in Denver, Colorado with district offices in Mount Clare, West Virginia; and Marietta, Ohio.

Advisors' Opinion:

• [By Robert Rapier]

  Normally, we wouldn’t be updating so soon buy recommendations made within the last month or so. Then again, we normally wouldn’t expect a decent year’s worth of gains in a month, so a look-around definitely seems in order.

  Marcellus and Utica driller Antero Resources (NYSE: AR) is up 13 percent (as of Dec. 27) since we added it to The Energy Strategist’s Growth Portfolio on Nov. 26, extending a rally that has made it one of the year’s most successful initial public offerings.
  

  There have been no company-specific news in the last months, but the prices of natural gas and, crucially, the natural gas liquids that will account for the bulk of Antero’s future profits, have moved significantly higher.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Antero Resources (NYSE: AR) were down 3.64 percent to $60.92 after the company announced a 105% y/y gain in its Q1 preliminary gas production.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Antero Resources (NYSE: AR) were down 5.41 percent to $59.74 after the company announced a 105% y/y gain in its Q1 preliminary gas production.